Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Elimination and Biodegradation of the Incretin Hormones GLP-1 and GIP in Patients With End-stage Renal Disease

NCT01391884 is registered in ClinicalTrials.gov with Bo Feldt-Rasmussen as lead sponsor.

NCT NCT01391884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01391884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Elimination and Biodegradation of the Incretin Hormones GLP-1 and GIP in Patients With End-stage Renal Disease
Lead sponsor
Bo Feldt-Rasmussen
Phase
Observational
Overall status
Completed
Start date
June 30, 2011
Completion date
June 30, 2012
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uremia